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Abstract
Introduction—Patients must have transportation to the treatment site before they can access
appropriate cancer care. This paper describes factors associated with patients experiencing
transportation-related barriers to accessing cancer care.
Patients and Methods—The Cancer Care Assessment & Responsive Evaluation Studies (C-
CARES) questionnaire was mailed to VA colorectal cancer (CRC) patients during fall 2009.
Eligible patients were diagnosed at any VA facility in 2008, male, and alive at time of mailing. A
total of 1,409 surveys were returned (approximately 67% response rate). To assess transportation
barriers, patients were asked how often it was difficult to get transportation to or from treatment.
Symptoms were assessed using validated PROMIS scales for fatigue, pain, and depression.
Multivariate logistic regression was used to examine determinants of transportation barriers.
Results—A minority (19%) of respondents reported transportation barriers. Patients
experiencing pain (OR 1.04, 95% CI 1.02, 1.06) had greater odds of transportation barriers than
patients without this symptom. Patients who reported no primary social support (OR 6.13, 95% CI
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3.10, 12.14) or non-spousal support (OR 2.00, 95% CI 1.40, 2.87) were more likely to experience
transportation barriers than patients whose spouse provided social support.
Discussion—Patients with uncontrolled pain or less social support have greater odds of
transportation barriers. The directional association between social support, symptoms, and
transportation cannot be determined in this data.
Conclusion—Inquiring about accessible transportation should become a routine part of cancer
care, particularly for patients with known risk factors.
Keywords
transportation; access to health care; colorectal neoplasms; health services research; veterans
affairs
INTRODUCTION
Transportation to and from treatment is an important and often overlooked aspect of cancer
care quality continuum.1,2 Extensive research has been conducted examining lack of
transportation as a barrier for cancer screening.3,4 In contrast to the literature regarding
cancer screening, transportation barriers among patients undergoing active treatment have
received considerably less research attention and continue to be a problem. Difficulty with
transportation is a problem for many cancer patients – limiting access to healthcare services
and hindering a patient’s likelihood of obtaining appropriate cancer care. Longer
transportation time to health services has been associated with increased burdens on time,
cost to the patient, and patient discomfort.5 Travel distances are also important because
patients may not have local services or may bypass local services due to lack of confidence
in their quality.5 This may result in an increased burden on both cancer patients and their
caregivers.7
It has been previously reported that an estimated 13-14% of cancer patients experience
transportation problems related to obtaining care.6 Problems with transportation and other
access to healthcare have been shown to predominately affect the elderly8,9, those who live
in rural areas1,5,8,10-12, racial and ethnic minorities9, patients with lower annual household
income 6,9,10,13, and patients with less social support.1,9,10,13 Therefore, it may be
particularly important to examine transportation issues in colorectal cancer patients who are
older, non-white, and who present with later stage disease at diagnosis.
Little is known about the transportation difficulties of veterans with cancer who receive their
care at a VA facility. Eligible Veterans have access to the largest integrated healthcare
service network in the county, including 143 VA medical centers offering cancer treatment
services. However, Veterans are more likely to live in rural areas and have lower incomes
than the general public, two factors previously linked with transportation barriers.14 In
addition, within the VA healthcare system there is further regionalization of certain
procedures such as bone marrow transplantation.15 As a result, there may be persistent
access issues for VA patients.
The aims of the present study are to determine the level of healthcare-related transportation
difficulty reported by VA colorectal cancer patients and identify patient-level determinants
of experiencing transportation as a barrier to cancer care. We hypothesized that, after
controlling for patient and disease characteristics, patients with limited access to informal
caregiving, lower annual income, and higher symptoms will have greater odds of reporting
that transportation difficulties are a barrier affecting their ability to access cancer care.
Zullig et al. Page 2














The present study utilizes survey data from VA patients with colorectal cancer diagnosed in
2008. The protocol for survey administration and use of data for analysis were approved by
the Institutional Review Board (IRB) of the Minneapolis VA Medical Center and University
of Minnesota School of Medicine. The Durham VA Medical Center IRB also approved
using survey data for analysis.
The C-CARES Survey
The Cancer Care Assessment and Responsive Evaluation (C-CARES) survey was developed
though a consortium of researches representing VA Health Services Research &
Development, Department of Defense, National Cancer Institute, and the University of
Minnesota. The goal of C-CARES was to obtain patient-reported symptoms, symptom
management, and the patient-reported experience with the VA healthcare system among
newly diagnosed colorectal cancer patients. A consensus panel of VA and non-VA
researchers, psychometricians, and clinicians identified items for inclusion in the survey.
Patient Identification and Survey Mailing
Patients were identified through the VA Central Cancer Registry (VACCR). The VACCR
uses custom software (OncoTraX) that integrates with the VA electronic health record
system to identify all cancer cases diagnosed and treated within VA, making it a
comprehensive resource for patient identification. It has been estimated that VACCR
captures approximately 90% of cancer cases treated in VA.21
Our study aimed to survey 100% of eligible patients newly diagnosed with colorectal cancer
in 2008. To be included in the survey cohort, patients had to meet the following eligibility
criteria: 1) newly diagnosed with colorectal cancer during calendar year 2008, 2) received
over half of their cancer care at any medical center in the VA healthcare system, and 3) be
living at the time of the mailing. After attaining the initial list from the VACCR (n=2,555), a
research assistant at the Minneapolis VA manually reviewed patients’ electronic medical
record to confirm eligibility criteria, including vital status, and to identify the patient’s
mailing address to which the survey would be sent. Surveys were mailed to 2,090 patients
between August and November 2009.
The C-CARES survey was administered in paper-pencil format, mailed directly to the
patients’ homes. The C-CARES survey was developed for an eighth grade reading level. A
ten-dollar incentive was included in the survey packet.
A total of 1,409 surveys were returned, resulting in an overall response rate of
approximately 67%. Individuals who indicated that they received most of their cancer care
outside of the VA were excluded from analysis. After this secondary eligibility screening
process, there were a total of 1,147 surveys remaining for analysis. Additional exclusion
criteria were applied post-hoc. There were few female respondents (n=30). The small
number of women rendered gender comparisons infeasible and there is reason to suspect that
women may perceive barriers to care differently than their male counterparts.22 Therefore,
women’s surveys were excluded from this analysis. Some surveys were returned with
incomplete information regarding presence of symptoms or other key factors (n=116).
Surveys missing this information were excluded. This resulted in a final number of 954
surveys for inclusion in analysis (Figure 1).
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The outcome variable, transportation difficulties, was derived from the following question in
the C-CARES survey: “How often was it difficult to get transportation to or from your
treatment or follow-up appointment?” Response options were: ‘does not apply’, ‘never’,
‘sometimes’, ‘often’ and ‘always’. Patients who responded in the latter two categories were
coded as having a transportation barrier. Symptoms were assessed using dichotomized
survey items from validated scales for fatigue, pain, and depression.
Explanatory Variables
Measures of patient characteristics, disease characteristics, and symptoms were included as
explanatory and control variables. Attributes of the patient included age (continuous), race
(categorical), employment status (binary), educational level (binary), and income
(categorical). Age was measured as a continuous variable describing the age at diagnosis of
CRC. Race information was aggregated into four mutually exclusive categories: white,
black, Hispanic, or other race. There were two hierarchical sources of racial information. We
first used the race category indicated by the respondent on the returned survey. However,
race from the VA Central Cancer Registry was utilized if the patient failed to report a race
on the C-CARES survey. The C-CARES survey served as the sole data source for
employment status, educational level, and annual income. Respondents were coded as
employed if they reported any, part-or full-time, employment. A binary variable was created
to categorize educational level. Respondents who reported completing high school or
higher-level education were coded as one; respondents who reported partial completion of
high school or less education were coded as zero. Annual income was characterized in four
distinct categories: less than $10,000, between $10,000 and $20,000, between $20,001 and
$40,000, or greater than $40,000.
Low social support is a known predictor of transportation problems. 1,9,10,13 Many cancer
patients rely on their social support network to transport them to necessary treatment and
follow-up appointments. In order to assess the effect of social support on transportation,
patients were asked, “If you had to choose, which person is most likely to help or take care
of you, if you needed it?” Possible responses included: ‘my spouse’, ‘my daughter’, ‘my
son’, ‘my boyfriend/girlfriend or partner’, ‘another family member’, ‘a friend or neighbor’,
‘other’, and ‘no one would help or take care of me’. Responses were mapped into three
mutually exclusive variables indicating support from spouse, family and friends (apart from
the spouse), or no one.
In addition to patient characteristics, we also controlled for disease characteristics and
symptoms. Stage at diagnosis, a categorical variable, was included in the model. To assess
symptom severity within the last six months, C-CARES contained validated PROMIS scales
for depression, fatigue, and impact of pain.17,18 A t-score for each scale was calculated for
every respondent. PROMIS scale t-score distributions are standardized such that the mean
for the general U.S. population is 50 and the standard deviation around this mean is ten.18
Higher scores indicated greater severity of symptoms. In order for PROMIS scales to be
meaningful, patients must respond to all survey items. PROMIS scale calculation would not
be possible with incomplete data; surveys with missing information on any PROMIS
symptom survey item were excluded from analysis.
To assess fatigue, the C-CARES survey contained the validated PROMIS fatigue scale that
included six questions targeting presence of fatigue.17,23 “How often did you experience
extreme exhaustion?” and “How often did you run out of energy?” are examples of two
fatigue-related questions. Patients responded in one of the following categories for each
fatigue question: ‘never’, ‘rarely’, ‘sometimes’, ‘often’, or ‘always’.
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Similarly, the six validated PROMIS pain scale items were included in C-CARES.17,23 Two
examples of pain questions include, “How much did pain interfere with your enjoyment of
life?” and, “How much did pain interfere with your ability to concentrate?” Patients
indicated either: ‘not at all’, ‘a little bit’, ‘somewhat’, ‘quite a bit’, or ‘very much’.
Depression was assessed using the eight questions from the validated PROMIS depression
scale to assess problems with mood.17,23 Expressions of mood or depression problems
included, “I felt worthless” and, “I felt that I had nothing to look forward to.” Response
options included: ‘never’, ‘rarely’, ‘sometimes’, ‘often’, or ‘always’. The PROMIS scale t-
scores were then calculated separated for pain, fatigue, and depression.18
Analysis
Statistical analyses were performed using Stata (StataCorp. 2007. Stata Statistical Software:
Release 10. College Station, TX: StataCorp LP). We conducted multivariable logistic
regression analysis to determine the likelihood that patients with certain personal, disease,
and symptom characteristics would report transportation-related barriers to receiving cancer
treatment.
RESULTS
The respondents ranged in age from 26 to 90 years of age (Table 1). The mean age of
respondents was 68 years, with a standard deviation of approximately 10. Respondents were
predominately white (76%). Approximately 13% of respondents were black, 6% were
Hispanic, and 5% reported another race. The majority of survey respondents reported their
spouse as their primary source of social support (50%). Approximately 40% of survey
respondents reported that another, non-spousal family member or friend cares for them.
Nearly 5% reported no source of social support. The majority of respondents reported
having a high school diploma or higher as their level of education (83%). Half of
respondents reported an income of $10,000 to $20,000. However, 82% of respondents
reported that they did not have either full- or part-time employment at the time of the survey
response.
Disease characteristics and symptoms were also examined. The greatest proportion of
patients were diagnosed with Stage I disease (36%), followed by Stage II (26%), Stage III
(21%), and Stage IV (17%). Respondents reported symptom levels of pain (mean=51.1,
SD=10.6), fatigue (mean=52.9, SD=9.7), and depression (mean=50.5, SD=10.9) comparable
to the mean PROMIS scale values.
A minority (19%) of respondents reported transportation barriers. While this number is
relatively low, it is slightly higher than the 13-14% estimates among the broader cancer
population.6 This number of patients suggests that transportation may be a meaningful
barrier for one in five Veterans attempting to access cancer care within the VA healthcare
system.
Multivariable logistic regression was utilized to examine determinants of experiencing
transportation as a barrier to accessing cancer care. Having access to an informal caregiver
had a strong statistically significant effect on the odds of transportation being a barrier to
cancer care. Respondents who reported that a friend or family member would take care of
them had two-times greater odds (OR=2.00, 95% CI=1.40, 2.87) of experiencing
transportation problems than respondents who reported that their spouse would help them.
Similarly, respondents who indicated that no one would take care of them had six-times
greater odds (OR=6.13; 95% CI=3.10, 12.14) of experiencing transportation problems than
patients who would rely on their spouse (Table 2).
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The effect of symptoms on experiencing a transportation barrier was also assessed. There
was a statistically significant association between uncontrolled pain (OR=1.04; 95%
CI=1.02, 1.06) and experiencing a transportation barrier. However, fatigue (OR=1.02; 95%
CI=0.99, 1.05) and depression (OR=1.02; 95% CI=0.99, 1.04) were not associated with
greater odds of experiencing a transportation problem.
Patient demographic characteristics and cancer stage were not found to have a statistically
significant effect on the transportation barrier. Further, there was no association between
age, race, stage at diagnosis, having attained less than a high school equivalent level of
education, not having full- or part-time employment, or income on experiencing a
transportation problem (Table 2).
DISCUSSION
Transportation is an important, yet often overlooked, element in the delivery of high quality
and accessible cancer care.1,5,6,8,10,11,13 Patients with colorectal cancer may undergo
surgery, chemotherapy, and in some cases, radiation therapy.24,25 Patients undergoing
different types of treatment, based on stage and other disease characteristics, will interact
with the healthcare system with varying frequency. As a result, transportation needs may
vary at different points along the cancer care continuum. Receiving each of these services
hinges on the patient’s ability to get to the needed care. Patients who may already be
disadvantaged due to lack of social support or uncontrolled pain symptoms have increased
odds of experiencing transportation barriers that limit access to cancer care.10,13,26,27
The results of the C-CARES survey indicate that VA colorectal cancer patients may
experience transportation problems at an increased rate, approximately 19%, compared to
the general U.S. cancer population. Among non-VA cancer patients, an estimated 13 to 14
percent report transportation as a barrier to receiving care.6 This may, in part, be due to
where Veteran cancer patients live. The literature suggests that transportation barriers are
highly associated with the geographic location where the patient resides.11,28,29 Further
analyses are needed to assess whether region of the country or distance to care are predictors
of transportation barriers among the VA cancer patient population.
Patients who are currently experiencing symptoms related to their cancer or cancer care may
need ongoing treatment even more than asymptomatic patients. However, respondents who
report problems with fatigue, pain, or their mood are more likely to have problems getting
the needed transportation. This may place them at increased risk for ongoing, poorly
controlled symptoms.
This study has limitations that should be considered. The C-CARES survey focused on
patients with colorectal cancer. It is possible that patients with other forms of cancer may
experience different transportation challenges. Additionally, the C-CARES survey was
mailed to patients’ home addresses. Homeless and transient patients may not have a home
address and therefore would not have been surveyed. Patients responding to this survey were
not the sickest of all cancer patients in the VA. In order to be mailed a survey, patients must
have survived a minimum of approximately nine months post-diagnosis and had to be well
enough to respond. Furthermore, patients undergoing different types of treatment modalities
may have differing transportation needs. Among C-CARES respondents, relatively few
patients (19%) reported that transportation was a problem in getting to their cancer
treatment. Future studies with a larger patient cohort should assess differences in
experiencing a transportation barrier based on type of treatment received. The C-CARES
survey was designed to globally understand patients’ experiences with cancer care.
Assessing transportation was not a core element in the C-CARES instrument. As a result,
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several important variables were not included. C-CARES did not ask patients about their
usual source of transportation to care (e.g. private car, public transportation), whether
patients lived in a rural or urban area or region of the country. C-CARES also did not ask for
patients’ service connected status. This is an important factor for determining patient
eligibility for certain VA services at reduced or no cost. Furthermore, the analyses were
based on cross-sectional data. Thus, the direction of the relationship between symptoms and
transportation barriers is uncertain. It is possible that higher transportation barriers may
result in worse symptom management. For example, clinicians may be more willing to
prescribe opiates to the cancer patient in their examination room than for the cancer patient
who telephone calls the clinic, but cannot be physically present for an appointment.
Based on the current analysis, it is not possible to determine that transportation is a causal
barrier to cancer care. It is also feasible that poorly managed cancer care could result in
transportation problems. Additional research is needed in this area.
CONCLUSION
VA colorectal cancer patients may experience transportation as a barrier to receiving cancer
treatment. Patients who lack of social support or have poorly managed pain symptoms are
more likely to experience problems with transportation to treatment. Screening patients for
transportation problems should become a routine part of VA primary care or early cancer
visits, particularly for elderly patients, minorities, and those known to reside in rural areas.
VA cancer care providers should be equipped to inform patients about available public and
volunteer transportation options available. VA has widely offered transportation services
including the Disabled American Veterans (DAV) transportation network and other
hospital-driven or voluntary services.30
CLINICAL PRACTICE POINTS
Transportation is a known barrier to care for many cancer patients. Previous literature has
documented that elderly patients8,9, those who live in rural areas1,5,8,10-12, minorities9,
patients with lower annual household income 6,9,10,13, and patients with reduced social
support.1,9,10,13 may be at increased risk for experiencing a transportation barrier. Much
previous work focuses on cancer screening. This study suggests that VA colorectal cancer
patients experience transportation as an access barrier to cancer care throughout their initial
cancer treatment. This finding should impact the way that clinicians approach their
colorectal cancer patients. Clinicians should be mindful that transportation is a problem for
many patients and should screen them accordingly. Clinicians should also be equipped to
inform patients about available public and volunteer transportation options available.
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Table 1
Characteristics of survey respondents (n=954)
Percent SD Min Max
Patient Characteristics
 Age 68.3 10.01 26 90
 Male 100.0 -- -- --
 White race 76.4 -- -- --
 Black race 13.1 -- -- --
 Hispanic 5.6 -- -- --
 Other race 4.9 -- -- --
Employment and Educational Status
 Employed 17.9 -- -- --
 Not employed 82.1 -- -- --
 High school or higher education 82.5 -- -- --
 Less than high school education 17.5 -- -- --
Annual Income
 < $10,000 16.0 -- -- --
 $10,000 - $20,000 50.0 -- -- --
 $20,001 - $40,000 23.6 -- -- --
 > $40,000 10.4 -- -- --
Social Support
 Spouse 50.1 -- -- --
 Family and friends 40.1 -- -- --
 No one 4.6 -- -- --
Stage at Diagnosis
 Stage I 36.0 -- -- --
 Stage II 25.6 -- -- --
 Stage III 21.1 -- -- --
 Stage IV 17.4 -- -- --
Symptoms
 Fatigue 52.9 9.7 32.5 82.7
 Pain 51.1 10.6 41.0 78.3
 Mood problems 50.5 10.9 37.1 81.1
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Table 2
Multivariate logistic regression results describing factors affecting transportation to cancer treatment (n=954)
OR 95% CI p
Patient Characteristics
 Age 1.00 (0.98, 1.02) 0.85
 Race 1.21 (0.99, 1.49) 0.06
 Not employed† 1.14 (0.69, 1.90) 0.60
 Less than high school education†† 0.72 (0.43, 1.20) 0.21
Annual Income †††
 < $10,000 1.86 (0.89, 3.85) 0.10
 $10,000 - $20,000 1.54 (0.79, 3.00) 0.20
 $20,001 - $40,000 1.16 (0.56, 2.36) 0.69
Social Support ††††
 Family and friends 2.00 (1.40, 2.87) 0.00*
 No one 6.13 (3.10-12.14) 0.00*
Disease Characteristics & Symptoms
 Stage 0.96 (0.82, 1.12) 0.59
 Fatigue 1.02 (0.99, 1.05) 0.10
 Pain 1.04 (1.02, 1.06) 0.00*




The referent employment status category is part- or full-time employment.
††
The referent educational category is completion of high school or greater.
†††
The referent annual income category is >$40,000.
††††
The referent social support category is spouse.
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